SCHEMBL7553158

SCHEMBL7553158

COc1cccc(N)c1NC(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.54
CA1 P00915 5/20 0.50
CA2 P00918 5/20 0.50
ACHE P22303 4/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
MGLL Q99685 2/20 0.48
POLB P06746 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
AAK1 Q2M2I8 1/20 0.46
HDAC3 O15379 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3783994 0.81 MGLL (0.50) CASP3CA1CA2NPC1RAB9A
SCHEMBL7555126 0.80 CASP3 (0.51) CASP3CA1CA2ACHENPC1
SCHEMBL3784496 0.80 MGLL (0.56) CASP3CA1CA2NPC1RAB9A
SCHEMBL7554216 0.79 KMT2A (0.53) CASP3CA1CA2ACHENPC1
SCHEMBL5112374 0.78 CA12 (0.47) CA1CA2SMN1; SMN2POLBKMT2A
SCHEMBL27943694 0.78 MGLL (0.56) NPC1RAB9ASMN1; SMN2MGLLPOLB
SCHEMBL4210145 0.78 KMT2A (0.56) CA1CA2ACHENPC1RAB9A
SCHEMBL11694836 0.78 TP53 (0.57) NPC1RAB9ASMN1; SMN2MGLLPOLB
SCHEMBL5233194 0.77 NPC1 (0.51) CASP3CA1CA2ACHENPC1
SCHEMBL3784676 0.77 MGLL (0.49) CASP3CA1CA2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218352-A1 BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY BOEHRINGER INGELHEIM ITALIA S.p.A. (IT) 2002-07-03 EP disclosed
US-6281218-B1 USEFUL IN THE TREATMENT OF CNS DISORDERS. INGELHEIM ITALIA S.P.A. (IT) 2001-08-28 US disclosed
WO-2001021593-A1 NEW BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY BOEHRINGER INGELHEIM ITALIA S.P.A. (IT) 2001-03-29 WO disclosed
EP-0285000-A2 Chromogene compounds, their manufacture and use as enzyme substrates Roche Diagnostics GmbH (DE) 1988-10-05 EP disclosed